首页 > 市场调查报告书 > 医疗设备

电子医疗设备

北美神经刺激设备市场预测至 2030 年 - 区域分析 - 按产品、应用和最终用户

市场调查报告书

商品编码

1494499

北美神经刺激设备市场预测至 2030 年 - 区域分析 - 按产品、应用和最终用户

North America Neurostimulation Devices Market Forecast to 2030 - Regional Analysis - by Product, Application, and End User

出版日期: 2024年04月05日 | 出版商:

The Insight Partners | 英文 85 Pages | 订单完成后即时交付

价格

简介目录图表

2022年北美神经刺激设备市值为24.2264亿美元，预计2030年将达到500080万美元；预计2022年至2030年复合年增长率为9.5%。

神经系统疾病盛行率的增加推动了北美神经刺激设备市场的发展

老年族群是神经系统疾病的易感族群。影响老年人的常见神经系统疾病有神经病变、帕金森氏症、阿兹海默症、肌张力失调等。根据美国国立卫生研究院 (NIH) 的数据，世界人口的 8.5%（即约 6.17 亿人）年龄在 65 岁及以上。美国和加拿大等国家与老年人口成长相关的运动障碍和精神疾病盛行率很高。根据帕金森基金会的数据，帕金森症状在平均 60 岁的人群中很常见。世界卫生组织 (WHO) 指出，癫痫是一种引起癫痫发作的神经系统疾病，影响全球 5,000 万人。根据美国神经学学会的数据，中风是美国第三大死因，其次是阿兹海默症，是第六大死因。来自同一来源的统计数据显示，近100万美国人受到帕金森氏症的影响，每年至少报告6万例新病例。神经系统疾病的发生率不断上升，加上忧郁症和慢性疼痛等与生活方式相关的疾病，导致越来越多地采用先进技术产品。据世界卫生组织称，神经疾病占全球疾病负担的 6.3%。此外，根据同一消息来源，这些疾病是世界各地死亡的主要原因之一。在已开发国家，其死亡人数占 13.2%，在低收入和中等收入国家，则占 16.8%。高死亡率和疾病负担使得临床迫切需要整合长期解决方案。此外，人们越来越认识到神经系统疾病的巨大负担，增加了对神经刺激器作为治疗方法的需求。因此，容易患神经系统疾病的老年人口不断增加，疾病盛行率不断增加，以及人们对神经系统疾病巨大负担的认识不断提高，推动了神经刺激设备市场的成长。

北美神经刺激设备市场概况

北美神经刺激设备市场分为美国、加拿大和墨西哥。由于神经系统疾病的日益普及、研发支出的高额、美国食品药物管理局（FDA）的产品批准以及技术的进步，预计北美将在全球神经刺激设备市场中占据重要份额。易患神经系统疾病的老年人口不断增加，预计将在预测期内为该地区的市场成长提供利润丰厚的机会。此外，政府为解决人们对脑部疾病日益增长的担忧而提供的越来越多的支持预计将推动该地区的市场成长。在美国，神经血管疾病的发生率正在显着上升，是全国主要死亡原因之一。帕金森氏症 (PD) 等神经系统疾病发病率的上升、人们对神经系统疾病的认识不断提高以及对开发经颅刺激器的投资不断增加，是推动美国整体神经刺激设备市场的主要因素。据观察，深部脑部刺激（DBS）设备可以有效控制与帕金森氏症相关的震颤。低多巴胺读数和其他遗传因素是帕金森氏症的主要原因。

北美神经刺激设备市场收入及 2030 年预测（百万美元）

北美神经刺激设备市场细分

北美神经刺激设备市场根据产品、应用、最终用户和国家进行细分。

根据产品，北美神经刺激设备市场分为脊髓刺激器、深部脑部刺激器、荐神经刺激器、迷走神经刺激器等。 2022 年，脊髓刺激器细分市场占据最大的市场。

从应用来看，北美神经刺激设备市场分为疼痛管理、癫痫、失禁、巴金森氏症等。 2022 年，疼痛管理领域占据最大的市场。

依最终用户划分，北美神经刺激设备市场分为医院、专科诊所等。 2022 年，医院细分市场占据最大的市场份额。

根据国家/地区，北美神经刺激设备市场分为美国、加拿大和墨西哥。 2022 年，美国在北美神经刺激设备市场份额中占据主导地位。

Medtronic Plc、Boston Scientific Corp、Abbott Laboratories、Nevro Corp、LivaNova Plc、Synapse Biomedical Inc、Nalu Medical Inc、ElectroCore Inc、MicroTransponder Inc 和 Mainstay Medical 是北美神经刺激设备市场上的一些领先公司。

Geriatric population is susceptible to neurological diseases. Common neurological disorders affecting older people are neuropathy, Parkinson's disease, Alzheimer's disease, dystonia, and others. As per the National Institutes of Health (NIH), 8.5% of the world's population (i.e., around 617 million people) is aged 65 years and above. Countries such as the US and Canada have high prevalence rates of movement disorders and psychiatric disorders associated with growing geriatric populations. According to the Parkinson's Foundation, Parkinson's symptoms are common at an average age of 60. The Canadian Psychological Association states that obsessive-compulsive disorder (OCD) affects about 2% of the population in Canada. The World Health Organization (WHO) states that epilepsy is a seizure-causing neurological disorder that affects 50 million people worldwide. As per the American Academy of Neurology, stroke is the third leading cause of death in the US, followed by Alzheimer's as the sixth leading cause of death. Statistics from the same source show that nearly one million Americans are affected by Parkinson's, and at least 60,000 new cases are reported annually. The growing incidence of neurological diseases coupled with lifestyle-related disorders such as depression and chronic pain leads to the increasing adoption of technologically advanced products. According to the WHO, nervous disorders contribute to 6.3% of the global disease burden. Also, according to the same source, the disorders are one of the leading causes of deaths across the world. They cause 13.2% of deaths in developed countries and 16.8% in low- and middle-income countries. High mortality and disease burden necessitate the clinical urgency for integrating long-term solutions. Furthermore, growing awareness regarding the tremendous burden of neurological disorders has increased the demand for neurostimulators as a therapy. Therefore, the growing geriatric population prone to neurological diseases, increasing prevalence of the diseases, and rising awareness regarding the tremendous burden of neurological disorders drive the neurostimulation devices market growth.

North America Neurostimulation Devices Market Overview

The North America neurostimulation devices market is segmented into the US, Canada, and Mexico. North America is expected to hold a significant share of the global neurostimulation devices market owing to the growing prevalence of neurological diseases, high spending on research and development, product approvals by the US Food and Drug Administration (FDA), and technological advances. The rising geriatric population prone to neurological diseases is expected to offer lucrative opportunities for market growth in the region during the forecast period. Further, the growing support from the government to address the rising concerns about brain diseases is expected to boost market growth in the region. In the US, the incidence of neurovascular diseases is rising significantly, and it is among the leading causes of death across the country. Rising incidence of neurological diseases such as Parkinson's disease (PD), increasing awareness about neurological disorders, and growing investments in developing transcranial stimulators are among the main factors driving the overall neurostimulation devices market in the US. Deep brain stimulation (DBS) devices have been observed to control the tremors associated with Parkinson's disease effectively. Low dopamine readings and other genetic factors are among the main causes of Parkinson's disease.

North America Neurostimulation Devices Market Revenue and Forecast to 2030 (US$ Million)

North America Neurostimulation Devices Market Segmentation

The North America neurostimulation devices market is segmented based on product, application, end user, and country.

Based on product, the North America neurostimulation devices market is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held the largest market share in 2022.

In terms of application, the North America neurostimulation devices market is categorized into pain management, epilepsy, urinary and fecal incontinence, Parkinson's disease, and others. The pain management segment held the largest market share in 2022.

By end user, the North America neurostimulation devices market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the North America neurostimulation devices market is segmented into the US, Canada, and Mexico. The US dominated the North America neurostimulation devices market share in 2022.

Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, Nevro Corp, LivaNova Plc, Synapse Biomedical Inc, Nalu Medical Inc, ElectroCore Inc, MicroTransponder Inc, and Mainstay Medical are some of the leading companies operating in the North America neurostimulation devices market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Neurostimulation Devices Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Prevalence of Neurological Disorders
- 4.1.2 Rising Cases of Spinal Cord Injury
4.2 Market Restraints
- 4.2.1 Lack of Expert Professionals
4.3 Market Opportunities
- 4.3.1 Growing Advances and Approvals for Neurostimulation Devices
4.4 Future Trends
- 4.4.1 Rising Demand for Noninvasive Treatment
4.5 Impact Analysis

5. Neurostimulation Devices Market - North America Market Analysis

5.1 North America Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

6. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

6.1 Overview
6.2 North America Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Spinal Cord Stimulator
- 6.3.1 Overview
- 6.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Deep Brain Stimulator
- 6.4.1 Overview
- 6.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Sacral Nerve Stimulator
- 6.5.1 Overview
- 6.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Vagus Nerve Stimulator
- 6.6.1 Overview
- 6.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 North America Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Pain Management
- 7.3.1 Overview
- 7.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Epilepsy
- 7.4.1 Overview
- 7.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Urinary and Fecal Incontinence
- 7.5.1 Overview
- 7.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Parkinson's Disease
- 7.6.1 Overview
- 7.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

8.1 Overview
8.2 North America Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Specialty Clinics
- 8.4.1 Overview
- 8.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 - Country Analysis

9.1 North America: Neurostimulation Devices Market
- 9.1.1 Overview
- 9.1.2 North America: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  - 9.1.2.1 US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.2 US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.2.1 US: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.2.2 US: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.2.3 US: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.3 Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.4 Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.4.1 Canada: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.4.2 Canada: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.4.3 Canada: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.5 Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.6 Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.6.1 Mexico: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.6.2 Mexico: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.6.3 Mexico: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

10. Neurostimulation Devices Market-Industry Landscape

10.1 Overview
10.2 Organic Developments
- 10.2.1 Overview
10.3 Inorganic Developments
- 10.3.1 Overview

11. Company Profiles

11.1 Medtronic Plc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Boston Scientific Corp
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Abbott Laboratories
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Nevro Corp
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 LivaNova Plc
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Synapse Biomedical Inc.
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Nalu Medical, Inc
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 ElectroCore Inc
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 MicroTransponder Inc.
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Mainstay Medical
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Neurostimulation Devices Market Segmentation
Table 2. US Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 3. US Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 4. US Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 5. Canada Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 6. Canada Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 7. Canada Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. Mexico Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. Mexico Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. Mexico Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 11. Organic Developments Done by Companies
Table 12. Inorganic Developments Done by Companies
Table 13. Glossary of Terms, Neurostimulation Devices Market

List Of Figures

Figure 1. Neurostimulation Devices Market Segmentation, By Country
Figure 2. Neurostimulation Devices Market: Key Industry Dynamics
Figure 3. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints
Figure 4. North America Neurostimulation Devices Market Revenue (US$ Mn), 2020 - 2030
Figure 5. North America Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. North America Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. North America Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
Figure 18. Hospitals & Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. North America: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)
Figure 22. North America: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
Figure 23. US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)